EIF4H
MOLECULAR TARGETeukaryotic translation initiation factor 4H
EIF4H (eukaryotic translation initiation factor 4H) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting EIF4H
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Metronidazole | 1.10 | 2 |
| 2 | egcg | 0.69 | 1 |
| 3 | Rosmarinic Acid | 0.69 | 1 |
| 4 | Rutin | 0.69 | 1 |
| 5 | Corticosterone | 0.69 | 1 |
| 6 | Diphenhydramine | 0.69 | 1 |
| 7 | Hexachlorophene | 0.69 | 1 |
| 8 | Oxcarbazepine | 0.69 | 1 |
| 9 | Oxytetracycline | 0.69 | 1 |
| 10 | Phenoxybenzamine | 0.69 | 1 |
About EIF4H as a Drug Target
EIF4H (eukaryotic translation initiation factor 4H) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented EIF4H interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
EIF4H inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.